WHO Policy Perspectives on Medicines
Summary of WHO's strategic directions for medicines 2008-2013
OWER 11.1 Formulation and monitoring of comprehensive national policies on access, quality and use of essential medical products and technologies advocated and supported
Priority
Traditional medicine (TM) MTSP, WHA56.31, WHA62.13
Continue
Developing global guidance and technical support on establishing national
policies on TM/CAM products and practices
New focus on
Integrating TM within national health systems and PHC programmes, promoting research and development, training and good
manufacturing practices
No comments:
Post a Comment